The appetite suppression effect was not temporary
Diabetes Care 27:21782183 Ziegler D, Low P, Litchy W, Boulton AJ, Vinik AI, Freeman R, Samigullin R, Tritschler H, Munzel U, Maus J, Schtte K, Dyck PJ (2011) Efficacy and safety of antioxidant treatment with -lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial
Body Protection Compound 157 is famous for regenerating soft tissues such as muscles, and the gastrointestinal tract, promoting blood vessel growth and reducing inflammation
These side effects are typically mild and tend to diminish as the body adjusts to the medication
Liraglutide ameliorates renal injury in streptozotocin-induced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor-B pathway